Academic literature on the topic '32.001 + 34.02 (043.2)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '32.001 + 34.02 (043.2).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "32.001 + 34.02 (043.2)"

1

Kampf, Anthony R., Jakub Plášil, Barbara P. Nash, Ivan Němec, and Joe Marty. "Uroxite and metauroxite, the first two uranyl oxalate minerals." Mineralogical Magazine 84, no. 1 (2019): 131–41. http://dx.doi.org/10.1180/mgm.2019.57.

Full text
Abstract:
AbstractUroxite (IMA2018-100), [(UO2)2(C2O4)(OH)2(H2O)2]⋅H2O, and metauroxite (IMA2019-030), (UO2)2(C2O4)(OH)2(H2O)2, are the first two uranyl oxalate minerals. Uroxite was found in the Markey mine, Red Canyon, San Juan County, Utah, USA and in the Burro mine, Slick Rock district, San Miguel County, Colorado, USA. Metauroxite was found only in the Burro mine. Both minerals are post-mining secondary phases found in efflorescent crusts on mine walls. Uroxite occurs as light yellow striated blades exhibiting moderate neon-green fluorescence, ca 2 Mohs hardness with good {101} and {010} cleavages.
APA, Harvard, Vancouver, ISO, and other styles
2

Al-Kaisey, Ahmed M., Ramanathan Parameswaran, Christina Bryant, et al. "Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress." JAMA 330, no. 10 (2023): 925. http://dx.doi.org/10.1001/jama.2023.14685.

Full text
Abstract:
ImportanceThe impact of atrial fibrillation (AF) catheter ablation on mental health outcomes is not well understood.ObjectiveTo determine whether AF catheter ablation is associated with greater improvements in markers of psychological distress compared with medical therapy alone.Design, Setting, and ParticipantsThe Randomized Evaluation of the Impact of Catheter Ablation on Psychological Distress in Atrial Fibrillation (REMEDIAL) study was a randomized trial of symptomatic participants conducted in 2 AF centers in Australia between June 2018 and March 2021.InterventionsParticipants were random
APA, Harvard, Vancouver, ISO, and other styles
3

Frick, Mareike, Christopher Maximilian Arends, Joel Galan-Sousa, et al. "Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy." Blood 130, Suppl_1 (2017): 632. http://dx.doi.org/10.1182/blood.v130.suppl_1.632.632.

Full text
Abstract:
Abstract Background: Clonal hematopoiesis of indeterminate potential (CHIP) is defined by the presence of hematologic cancer associated mutations in the peripheral blood (PB) of at least 10% of elderly people without history of hematologic disorders (Genovese et al ., NEJM, 2014; Jaiswal et al ., NEJM, 2014). At present, caution is needed when predicting clinical consequences from CHIP in healthy people. An essential step towards a better understanding of CHIP requires identification of the cell of origin, clonal expansion patterns within the hematopoietic differentiation tree, and its dynamic
APA, Harvard, Vancouver, ISO, and other styles
4

Newbold, J. R., P. C. Garnsworthy, P. J. Buttery, D. J. A. Cole та W. Haresign. "Responses of British Friesian steers with or without implants of oestradiol-17β to undegradable dietary protein". Animal Science 46, № 2 (1988): 181–93. http://dx.doi.org/10.1017/s0003356100042239.

Full text
Abstract:
AbstractThe ability of the protein nutrition scheme proposed by the Agricultural Research Council (ARC, 1980, 1984) to predict responses to protein supply was examined in two experiments. In experiment 1, groups of nine British Friesian steers implanted with oestradiol-17β and nine non-implanted steers were fed from 133 to 300 kg live weight on each of four all-concentrate diets (metabolizable energy (ME) = 12 MJ/kg dry matter (DM)) containing ratios of soya-bean meal and formaldehyde-treated soya-bean meal such that undegradable protein (UDP) concentration was 19, 25, 32 or 42 g/kg DM. Rumen
APA, Harvard, Vancouver, ISO, and other styles
5

Katamesh, Bahga, Amrutha Mittapalli, Rong He, et al. "STAG2 and PHF6: Comparison of 2 X-Linked Gene Mutations in Myeloid Neoplasms." Blood 142, Supplement 1 (2023): 4304. http://dx.doi.org/10.1182/blood-2023-178244.

Full text
Abstract:
INTRODUCTION: The Stromal Antigen 2 ( STAG2), on Xq25, is the most common cohesin complex gene mutated in myeloid neoplasms (MN) (5-10%). STAG2 mutations ( STAG2m) were incorporated in the ELN2022 as AML-MDS defining genetic mutations inferring poor prognosis and is a genetic marker in IPSS-M risk stratification. The PHD-finger protein 6 ( PHF6) gene, on Xq26.3, is a tumor suppressor gene, mutated in 3% of MN, and is more common in T-ALL. PHF6m is believed to be a late event in MN with little data on its prognostic implications in MN. Both STAG2m and PHF6m are more prevalent in males, but thei
APA, Harvard, Vancouver, ISO, and other styles
6

Liu, Yang, Ali Tabarroki, Valeria Visconte, et al. "A Prognostic Scoring System for Unclassifiable MDS and MDS/MPN." Blood 120, no. 21 (2012): 1701. http://dx.doi.org/10.1182/blood.v120.21.1701.1701.

Full text
Abstract:
Abstract Abstract 1701 Patients with features of MDS and MDS/MPN who do not fulfill diagnostic criteria for a specific subtype of MDS and MDS/MPN are categorized by the WHO 2008 diagnostic criteria as MDS-U and MDS/MPN-U. MDS includes RCUD, RCMD, RARS, RAEB-1, RAEB-2, MDS-U and 5q- syndrome while MDS/MPN includes CMML, JMML, atypical CML and MDS/MPN-U. The natural history of patients who belong to these disease subtypes are hetergeneous. Although included in currently accepted prognostic scoring schemes like the International Prognostic Scoring System (IPSS) in MDS, Revised IPSS, and MD Anders
APA, Harvard, Vancouver, ISO, and other styles
7

Riaz, Wasif, John Pham, Ling Zhang, et al. "Prognostic Significance of VLA4 and CD44 Expression by Flow Cytometry in Multiple Myeloma (MM)." Blood 120, no. 21 (2012): 4975. http://dx.doi.org/10.1182/blood.v120.21.4975.4975.

Full text
Abstract:
Abstract Abstract 4975 Background: Our group has developed a peptide referred to as HYD1 which binds VLA-4 integrin/CD44 containing complex and induces necrotic cell death in myeloma cells (Nair et al Mol Cancer Ther 2009, Emmons et al, Mol Cancer Ther, 2011). Furthermore, we previously demonstrated in a small subset of MM patients that HYD1 was more active in specimens obtained from relapsed/refractory patients, a finding that correlated with VLA-4 expression. The frequency of expression and prognostic significance of two key surface markers VLA4 (very late antigen 4) and CD44 in patients wit
APA, Harvard, Vancouver, ISO, and other styles
8

Duàn, Hanna, Emmi Jokinen, Hanna Lähteenmäki, et al. "Genomic Subtypes of AML Define Sensitivity to NK Cell Cytotoxicity." Blood 144, Supplement 1 (2024): 329. https://doi.org/10.1182/blood-2024-199448.

Full text
Abstract:
Acute myeloid leukemia (AML) is characterized by poor prognosis and remains a challenging disease to treat. New therapeutic approaches are being introduced, and natural killer (NK) cell-based immunotherapy has been recognized as a promising option. However, which subgroups of AML patients that are most likely to respond to NK cell therapy, remain undefined. We explored the susceptibility of AML cells to NK cell cytotoxicity in ex vivo co-cultures. We analyzed leukemic cell sensitivity to NK cells using vitally frozen bone marrow (BM) samples from 99 AML patients at diagnosis and expanded NK ce
APA, Harvard, Vancouver, ISO, and other styles
9

Kröger, Nicolaus, Ernst Holler, Guido Kobbe, et al. "Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation." Blood 114, no. 26 (2009): 5264–70. http://dx.doi.org/10.1182/blood-2009-07-234880.

Full text
Abstract:
Abstract From 2002 to 2007, 103 patients with primary myelofibrosis or postessential thrombocythemia and polycythemia vera myelofibrosis and a median age of 55 years (range, 32-68 years) were included in a prospective multicenter phase 2 trial to determine efficacy of a busulfan (10 mg/kg)/fludarabine (180 mg/m2)–based reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation from related (n = 33) or unrelated donors (n = 70). All but 2 patients (2%) showed leukocyte and platelet engraftment after a median of 18 and 22 days, respectively. Acute graft-versus-host d
APA, Harvard, Vancouver, ISO, and other styles
10

Einsele, H., G. Ehninger, H. Hebart, et al. "Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation." Blood 86, no. 7 (1995): 2815–20. http://dx.doi.org/10.1182/blood.v86.7.2815.2815.

Full text
Abstract:
Abstract Culture-based preemptive therapy with ganciclovir was shown to reduce the incidence of cytomegalovirus (CMV) disease after bone marrow transplantation (BMT). Culture techniques did not detect CMV in 12% to 13% of patients before the onset of CMV disease. In a prospective study, 71 patients either received preemptive therapy based on polymerase chain reaction (PCR) technique (37 patients) or on culture assays (34 patients). In both groups, therapy was continued until clinical signs disappeared and PCR negativity was documented. Twenty-two patients in the PCR group and 15 patients in th
APA, Harvard, Vancouver, ISO, and other styles
More sources
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!